Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Seattle Genetics Inc (SGEN)

47.65 +0.15 (+0.32%)

8/23/2017  4:00pm

Open:

47.13

Pre. Close:

47.50

High:

48.42

Low:

46.99

Volume:

683,719

Market Cap:

6.82B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

48.87 - 49.63

49.63 - 50.13

Low:

45.45 - 46.11

46.11 - 46.54

Close:

46.66 - 47.87

47.87 - 48.65

Technical analysis  (as of: 2017-08-23 4:53:05 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 60.44     One year: 65.09

Support:

Support1: 45.31    Support2: 37.70

Resistance:

Resistance1: 51.75    Resistance2: 55.73

Pivot:

47.42

Moving Averages:

MA(5): 46.80     MA(20): 48.19

MA(100): 58.74     MA(250): 59.26

MACD:

MACD(12,26): -1.84     Signal(12,26,9): -2.10

%K %D:

%K(14,3): 38.61     %D(3): 26.22

RSI:

RSI(14): 39.79

52-Week:

High: 75.36  Low: 42.58  Change(%): 8.3

Average Vol(K):

3-Month: 109807  10-Days 11716

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
SGEN has closed below upper band by 45.3%. Bollinger Bands are 40.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to SGEN's normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 31 Jul 2017 19:52:30 GMT
Seattle Genetics results: The raw numbers

Tue, 01 Aug 2017 21:17:14 GMT
Seattle Genetics buys Bristol-Myers Squibb drug manufacturing facility in Bothell

Thu, 27 Jul 2017 19:52:30 GMT
BRIEF-Seattle Genetics Q2 loss per share $0.39

Thu, 17 Aug 2017 21:33:45 GMT
Seattle Genetics' Adcetris Granted Priority Review by FDA

Fri, 28 Jul 2017 15:56:15 GMT
Seattle Genetics (SGEN) Q2 Loss Narrower than Expected

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

143.03

Shares Float (M)

95.94

% Held by Insiders

27.15

% Held by Institutions

72.00

Shares Short (K)

10980

Shares Short Prior Month (K)

10550

Stock Financials

EPS

-1.270

EPS Est. Current Year

-1.700

EPS Est. Next Year

-1.160

EPS Est. Next Quarter

-0.450

Forward EPS

-1.080

Book Value (p.s.)

4.230

PEG Ratio

-0.06

Profit Margin

-47.38

Operating Margin

-48.22

Return on Assets (ttm)

-15.9

Return on Equity (ttm)

-32.7

Qtrly Rev. Growth

13.4

Gross Profit (p.s.)

2.628

Sales Per Share

EBITDA (p.s.)

-1.309

Qtrly Earnings Growth

Operating Cash Flow (M)

-154.92

Levered Free Cash Flow (M)

-116.10

FoxReading.com

Valuation

P/E

-37.52

P/E Growth Ratio

P/BV

11.26

P/S

2256748288.00

P/CF

-43.99

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.